These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
707 related articles for article (PubMed ID: 30390170)
1. Early diastolic strain rate measurements by cardiac MRI in breast cancer patients treated with trastuzumab: a longitudinal study. Gong IY; Ong G; Brezden-Masley C; Dhir V; Deva DP; Chan KKW; Graham JJ; Chow CM; Thavendiranathan P; Dai D; Ng MY; Barfett JJ; Connelly KA; Yan AT Int J Cardiovasc Imaging; 2019 Apr; 35(4):653-662. PubMed ID: 30390170 [TBL] [Abstract][Full Text] [Related]
2. Assessment of left ventricular function by CMR versus MUGA scans in breast cancer patients receiving trastuzumab: a prospective observational study. Dhir V; Yan AT; Nisenbaum R; Sloninko J; Connelly KA; Barfett J; Haq R; Kirpalani A; Chan KKW; Petrella TM; Brezden-Masley C Int J Cardiovasc Imaging; 2019 Nov; 35(11):2085-2093. PubMed ID: 31197526 [TBL] [Abstract][Full Text] [Related]
3. Longitudinal assessment of right ventricular structure and function by cardiovascular magnetic resonance in breast cancer patients treated with trastuzumab: a prospective observational study. Barthur A; Brezden-Masley C; Connelly KA; Dhir V; Chan KK; Haq R; Kirpalani A; Barfett JJ; Jimenez-Juan L; Karur GR; Deva DP; Yan AT J Cardiovasc Magn Reson; 2017 Apr; 19(1):44. PubMed ID: 28395671 [TBL] [Abstract][Full Text] [Related]
4. Serial Measurements of Left Ventricular Systolic and Diastolic Function by Cardiac Magnetic Resonance Imaging in Patients with Early Stage Breast Cancer on Trastuzumab. Song L; Brezden-Masley C; Ramanan V; Ghugre N; Barfett JJ; Chan KKW; Haq R; Petrella T; Dhir V; Jimenez-Juan L; Chacko BR; Kotha V; Connelly KA; Yan AT Am J Cardiol; 2019 Apr; 123(7):1173-1179. PubMed ID: 30683420 [TBL] [Abstract][Full Text] [Related]
5. Characterization of subclinical diastolic dysfunction by cardiac magnetic resonance feature-tracking in adult survivors of non-Hodgkin lymphoma treated with anthracyclines. Barbosa MF; Fusco DR; Gaiolla RD; Werys K; Tanni SE; Fernandes RA; Ribeiro SM; Szarf G BMC Cardiovasc Disord; 2021 Apr; 21(1):170. PubMed ID: 33845778 [TBL] [Abstract][Full Text] [Related]
6. Myocardial strain imaging by cardiac magnetic resonance for detection of subclinical myocardial dysfunction in breast cancer patients receiving trastuzumab and chemotherapy. Ong G; Brezden-Masley C; Dhir V; Deva DP; Chan KKW; Chow CM; Thavendiranathan D; Haq R; Barfett JJ; Petrella TM; Connelly KA; Yan AT Int J Cardiol; 2018 Jun; 261():228-233. PubMed ID: 29555336 [TBL] [Abstract][Full Text] [Related]
7. Serial Cardiovascular Magnetic Resonance Strain Measurements to Identify Cardiotoxicity in Breast Cancer: Comparison With Echocardiography. Houbois CP; Nolan M; Somerset E; Shalmon T; Esmaeilzadeh M; Lamacie MM; Amir E; Brezden-Masley C; Koch CA; Thevakumaran Y; Yan AT; Marwick TH; Wintersperger BJ; Thavendiranathan P JACC Cardiovasc Imaging; 2021 May; 14(5):962-974. PubMed ID: 33248962 [TBL] [Abstract][Full Text] [Related]
8. Comprehensive Assessment of Changes in Left Ventricular Diastolic Function With Contemporary Breast Cancer Therapy. Upshaw JN; Finkelman B; Hubbard RA; Smith AM; Narayan HK; Arndt L; Domchek S; DeMichele A; Fox K; Shah P; Clark A; Bradbury A; Matro J; Adusumalli S; Carver JR; Ky B JACC Cardiovasc Imaging; 2020 Jan; 13(1 Pt 2):198-210. PubMed ID: 31542526 [TBL] [Abstract][Full Text] [Related]
9. Left Ventricular Global Longitudinal Strain in HER-2 + Breast Cancer Patients Treated with Anthracyclines and Trastuzumab Who Develop Cardiotoxicity Is Associated with Subsequent Recovery of Left Ventricular Ejection Fraction. Fei HW; Ali MT; Tan TC; Cheng KH; Salama L; Hua L; Zeng X; Halpern EF; Taghian A; MacDonald SM; Scherrer-Crosbie M Echocardiography; 2016 Apr; 33(4):519-26. PubMed ID: 26992012 [TBL] [Abstract][Full Text] [Related]
10. Abnormalities in 3-Dimensional Left Ventricular Mechanics With Anthracycline Chemotherapy Are Associated With Systolic and Diastolic Dysfunction. Zhang KW; Finkelman BS; Gulati G; Narayan HK; Upshaw J; Narayan V; Plappert T; Englefield V; Smith AM; Zhang C; Hundley WG; Ky B JACC Cardiovasc Imaging; 2018 Aug; 11(8):1059-1068. PubMed ID: 29550306 [TBL] [Abstract][Full Text] [Related]
11. Cardiac magnetic resonance imaging-based myocardial strain study for evaluation of cardiotoxicity in breast cancer patients treated with trastuzumab: A pilot study to evaluate the feasibility of the method. Nakano S; Takahashi M; Kimura F; Senoo T; Saeki T; Ueda S; Tanno J; Senbonmatsu T; Kasai T; Nishimura S Cardiol J; 2016; 23(3):270-80. PubMed ID: 27173679 [TBL] [Abstract][Full Text] [Related]
12. Variability in echocardiography and MRI for detection of cancer therapy cardiotoxicity. Lambert J; Lamacie M; Thampinathan B; Altaha MA; Esmaeilzadeh M; Nolan M; Fresno CU; Somerset E; Amir E; Marwick TH; Wintersperger BJ; Thavendiranathan P Heart; 2020 Jun; 106(11):817-823. PubMed ID: 32098808 [TBL] [Abstract][Full Text] [Related]
13. Role of Early Left Atrial Functional Decline in Predicting Cardiotoxicity in HER2 Positive Breast Cancer Patients Treated With Trastuzumab. Bergamini C; Niro L; Springhetti P; Ferri L; Trento L; Minnucci I; Maffeis C; Tafciu E; Rossi A; Fiorio E; Benfari G; Ribichini F Cardiovasc Toxicol; 2024 Jun; 24(6):550-562. PubMed ID: 38696070 [TBL] [Abstract][Full Text] [Related]
14. Anthracyclines induce early changes in left ventricular systolic and diastolic function: A single centre study. Boyd A; Stoodley P; Richards D; Hui R; Harnett P; Vo K; Marwick T; Thomas L PLoS One; 2017; 12(4):e0175544. PubMed ID: 28407011 [TBL] [Abstract][Full Text] [Related]
15. 2D-echocardiography vs cardiac MRI strain: a prospective cohort study in patients with HER2-positive breast cancer undergoing trastuzumab. Bouwer NI; Liesting C; Kofflard MJM; Brugts JJ; Kock MCJ; Kitzen JJEM; Levin MD; Boersma E Cardiovasc Ultrasound; 2021 Nov; 19(1):35. PubMed ID: 34753503 [TBL] [Abstract][Full Text] [Related]
16. Assessment of left ventricular diastolic function during trastuzumab treatment in patients with HER2-positive breast cancer. Honda K; Takeshita K; Murotani K; Mitsuma A; Hayashi H; Tsunoda N; Kikumori T; Murohara T; Ando Y Breast Cancer; 2017 Mar; 24(2):312-318. PubMed ID: 27234030 [TBL] [Abstract][Full Text] [Related]
17. A Prospective Study About Trastuzumab-induced Cardiotoxicity in HER2-positive Breast Cancer. Ben Kridis W; Sghaier S; Charfeddine S; Toumi N; Daoud J; Kammoun S; Khanfir A Am J Clin Oncol; 2020 Jul; 43(7):510-516. PubMed ID: 32304433 [TBL] [Abstract][Full Text] [Related]
18. Cardiovascular magnetic resonance left ventricular strain in end-stage renal disease patients after kidney transplantation. Gong IY; Al-Amro B; Prasad GVR; Connelly PW; Wald RM; Wald R; Deva DP; Leong-Poi H; Nash MM; Yuan W; Gunaratnam L; Kim SJ; Lok CE; Connelly KA; Yan AT J Cardiovasc Magn Reson; 2018 Dec; 20(1):83. PubMed ID: 30554567 [TBL] [Abstract][Full Text] [Related]
19. Prolonged electromechanical delay as an early predictor of trastuzumab-induced cardiotoxicity in patients undergoing treatment for breast cancer. Choe JC; Choi JH; Choi JH; Ahn J; Park JS; Lee HW; Oh JH; Lee HC; Cha KS; Hong TJ Clin Cardiol; 2018 Oct; 41(10):1308-1314. PubMed ID: 30239009 [TBL] [Abstract][Full Text] [Related]
20. Single Versus Standard Multiview Assessment of Global Longitudinal Strain for the Diagnosis of Cardiotoxicity During Cancer Therapy. Thavendiranathan P; Negishi T; Coté MA; Penicka M; Massey R; Cho GY; Hristova K; Vinereanu D; Popescu BA; Izumo M; Negishi K; Marwick TH; JACC Cardiovasc Imaging; 2018 Aug; 11(8):1109-1118. PubMed ID: 29778856 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]